Abstract
Adenocarcinomas of the lower oesophagus and gastro-oesophageal junction are a complex clinico-pathological setting. Multimodality therapy is considered mandatory in most disease presentations. Nevertheless, the most appropriate treatment package has yet to be established. We herein summarize the evidence derived from randomized phase III trials on pre-operative treatments in this oncological scenario.
| Original language | English |
|---|---|
| Article number | 40 |
| Journal | Medical Oncology |
| Volume | 34 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Mar 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adenocarcinoma
- Gastro-oesophageal junction
- Neoadjuvant chemotherapy
- Oesophageal cancer
- Pre-operative chemo-radiation
- Radiotherapy
Fingerprint
Dive into the research topics of 'Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver